NCT06129136Completed
The Effect of Nature-based Exposure on the Immune System and Skin Health of Atopic Dermatitis Patients.
Source: ClinicalTrials.gov · Last updated 4 Apr 2025
Brief summary (registry, in English)
The purpose of the study is to explore the effect of nature-based exposure on immunological biomarkers and the condition and symptoms of atopic skin. Our hypothesis is that regular exposure to nature-based, high biodiversity material on skin, strengthens the skin's protective barrier and has a positive effect on the immunological biomarkers associated with atopic dermatitis. Further our hypothesis is that the difference between the groups (active and placebo) is noticeable during winter time when the disease is typically worse because of the cold weather. The study aim at scientific publication and is double-blinded and placebo-controlled. Time of the intervention is 6-7 months: intervention starts before the Finnish winter time and ends before the summer.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 142 (actual)
- First submitted
- 8 Nov 2023
- Start date
- 17 Aug 2023
- Primary completion date
- 17 Jun 2024
- Lead sponsor
- Uute Scientific Oy
- Diseases
- Atopic dermatitis (eczema)
- NCT number
- NCT06129136
What you commit to
- Study type: Interventional
- Participants enrolled: 142
- From 17 Aug 2023 to the primary completion date, 17 Jun 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Medication that suppresses the immune system (excluding antihistamines)
Other illness
- Cancer or cancer treatments
- Skin infection (such as a eczema that required antibiotic cream or a parasitic infection, e.g.scabies mite) during the last 6 months
- Psoriasis or other skin disease affecting the study in addition to atopy
Other
- Systemic medicine intended for the treatment of atopic dermatitis (orally or as an injection, other than an antihistamine) or the use of clinical phototherapy in the last 6 months.
- Atopic dermatitis that required hospitalization in the last 2 years
- Pregnancy or breastfeeding
Who the study is looking for
- A person aged 18-65, legally competent
- Meets Hanifin \& Rajka's criteria for atopic dermatitis in the initial interview and eczema has also appeared regularly in adulthood
- The possibility to commit to the research
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Uute Scientific Oy Coordinator of this site? Confirm its status | Helsinki | Finland | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.